IE35439B1 - Labelled sulphated polysaccharide compositions - Google Patents
Labelled sulphated polysaccharide compositionsInfo
- Publication number
- IE35439B1 IE35439B1 IE862/71A IE86271A IE35439B1 IE 35439 B1 IE35439 B1 IE 35439B1 IE 862/71 A IE862/71 A IE 862/71A IE 86271 A IE86271 A IE 86271A IE 35439 B1 IE35439 B1 IE 35439B1
- Authority
- IE
- Ireland
- Prior art keywords
- compositions
- labelled
- sulphated
- sulphated polysaccharide
- iodine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
1355559 Diagnostic compositions G D SEARLE & CO 5 July 1971 [6 July 1970] 31396/71 Heading A5B [Also in Division C3] A diagnostic testing composition comprises a sulphated polysaccharide, e.g. sulphated potato starch amylopectin, or the metal salt thereof, of molecular weight at least one million combined with a dyestuff, e.g. a thiazindye such as methylene blue (for endoscopic examinations) or with a radionuclide, e.g. iodine-125, iodine-131 or technetium-99m for examinations using radiation imaging devices. The compositions can be administered orally in conventional manners or parenterally.
[GB1355559A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5270770A | 1970-07-06 | 1970-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE35439L IE35439L (en) | 1972-01-06 |
IE35439B1 true IE35439B1 (en) | 1976-02-18 |
Family
ID=21979383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE862/71A IE35439B1 (en) | 1970-07-06 | 1971-07-06 | Labelled sulphated polysaccharide compositions |
Country Status (12)
Country | Link |
---|---|
BE (1) | BE769554A (en) |
CA (1) | CA946741A (en) |
CH (1) | CH565559A5 (en) |
DE (1) | DE2133005A1 (en) |
ES (1) | ES392966A1 (en) |
FR (1) | FR2100869B1 (en) |
GB (1) | GB1355559A (en) |
IE (1) | IE35439B1 (en) |
IL (1) | IL37244A (en) |
NL (1) | NL7109318A (en) |
SE (1) | SE399821B (en) |
ZA (1) | ZA714438B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
US5310538A (en) * | 1993-03-11 | 1994-05-10 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract |
US5312616A (en) * | 1993-03-11 | 1994-05-17 | Sterling Winthrop Inc. | Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE372421B (en) * | 1968-04-01 | 1974-12-23 | Minnesota Mining & Mfg |
-
1971
- 1971-07-02 DE DE19712133005 patent/DE2133005A1/en active Pending
- 1971-07-05 GB GB3139671A patent/GB1355559A/en not_active Expired
- 1971-07-06 SE SE7108719A patent/SE399821B/en unknown
- 1971-07-06 ES ES392966A patent/ES392966A1/en not_active Expired
- 1971-07-06 IE IE862/71A patent/IE35439B1/en unknown
- 1971-07-06 BE BE769554A patent/BE769554A/en unknown
- 1971-07-06 ZA ZA714438A patent/ZA714438B/en unknown
- 1971-07-06 CA CA117,489A patent/CA946741A/en not_active Expired
- 1971-07-06 NL NL7109318A patent/NL7109318A/xx unknown
- 1971-07-06 CH CH989571A patent/CH565559A5/xx not_active IP Right Cessation
- 1971-07-06 FR FR7124697A patent/FR2100869B1/fr not_active Expired
- 1971-07-06 IL IL37244A patent/IL37244A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CH565559A5 (en) | 1975-08-29 |
FR2100869B1 (en) | 1974-09-06 |
ZA714438B (en) | 1972-08-30 |
NL7109318A (en) | 1972-01-10 |
SE399821B (en) | 1978-03-06 |
CA946741A (en) | 1974-05-07 |
IL37244A0 (en) | 1971-10-20 |
BE769554A (en) | 1972-01-06 |
DE2133005A1 (en) | 1972-01-20 |
GB1355559A (en) | 1974-06-05 |
IL37244A (en) | 1974-07-31 |
ES392966A1 (en) | 1975-04-16 |
IE35439L (en) | 1972-01-06 |
FR2100869A1 (en) | 1972-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE28569T1 (en) | COMPOSITION CONTAINING A RADIOLABELED ANTIBODY, EQUIPMENT FOR THE PREPARATION THEREOF, AND CANCER OR TUMOR DETECTION EQUIPMENT CONTAINING SUCH COMPOSITION. | |
IE35326B1 (en) | Clathrate prostaglandins and compositions containing same | |
MY133974A (en) | Stable reagents for the preparation of radiopharmaceutiocals | |
HUP9802394A2 (en) | Sulfated oligosaccharides and pharmaceutical compositions containing them as active ingredients | |
UA32577C2 (en) | Radiolabeled compound as imaging agents for the diagnosis of arterial and venous thrombi, radiopharmaceuticals and radiopharmaceutical composition and kits for its preparation | |
DE19875032I2 (en) | Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing the same | |
GB1305442A (en) | ||
IE35439B1 (en) | Labelled sulphated polysaccharide compositions | |
IL39735A (en) | 3,20-dioxo-pregn-4-ene-21-oic acid derivatives | |
IT1011320B (en) | EQUIPMENT FOR THE PREPARATION OF RADIOISOTOPE COMPOSITIONS FOR EXAMPLE FOR CLINICAL DIAGNOSIS | |
CA948000A (en) | Age-hardening iron-base alloy with improved toughness | |
GB1261060A (en) | Phthalen-1-one derivatives | |
GB1521712A (en) | 5-acetyl-4-hydroxy-2h-pyran-2,6(3h)dione derivatives and pharmaceutical compositions comprising such compounds | |
DK128555B (en) | Process for the preparation of a diagnostic composition containing an <99> Tc-labeled iron complex. | |
GB1354263A (en) | Therapeutic composition | |
GB1268188A (en) | N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents | |
CA944979A (en) | Ductile corrosion-resistant alloys | |
IE35428L (en) | Benzodiazepines. | |
KR910002469A (en) | Method of manufacturing ^ 99mTC-labeled radiopharmaceutical for diagnosing liver and biliary tracts | |
GB1196871A (en) | Phthalimidine Derivative | |
GB1346317A (en) | Peptide enzyme inhibitor | |
GB1331852A (en) | Radiation sensitive polymers | |
GB1212119A (en) | Fecal softener | |
GB1488709A (en) | Photo-oxidizable compositions and elements | |
Fiorini et al. | Study of Aging Processes in Two New Al-Mg-Zn Alloys |